| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446163 | European Journal of Cancer | 2012 | 9 Pages |
Abstract
The incidence of kidney cancer has increased slightly, and survival improved modestly, resulting in a decreasing mortality. A positive effect of the introduction of targeted therapies for metastatic kidney cancer was observed in 1-year relative survival. For progress in kidney cancer care, effective prevention strategies and new therapies remain warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Saskia A.M. van de Schans, Katja K.H. Aben, Peter F.A. Mulders, John B.A.G. Haanen, Carla van Herpen, Rob H.A. Verhoeven, Henrike E. Karim-Kos, Egbert Oosterwijk, Lambertus A.L.M. Kiemeney,